These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 15743362

  • 1. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ, Lee SS.
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.
    Villanueva C, Planella M, Aracil C, López-Balaguer JM, González B, Miñana J, Balanzó J.
    Am J Gastroenterol; 2005 Mar; 100(3):624-30. PubMed ID: 15743361
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee WC, Lee FY, Chang FY, Lee SD.
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [Abstract] [Full Text] [Related]

  • 4. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
    Vorobioff JD, Ferretti SE, Zangroniz P, Gamen M, Picabea E, Bessone FO, Reggiardo V, Diez AR, Tanno M, Cuesta C, Tanno HE.
    Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
    [Abstract] [Full Text] [Related]

  • 5. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
    Abid S, Jafri W, Hamid S, Salih M, Azam Z, Mumtaz K, Shah HA, Abbas Z.
    Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC, Lin HC, Yang YY, Hou MC, Lee FY, Chang FY, Lee SD.
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [Abstract] [Full Text] [Related]

  • 7. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
    Silvain C, Carpentier S, Sautereau D, Czernichow B, Métreau JM, Fort E, Ingrand P, Boyer J, Pillegand B, Doffël M.
    Hepatology; 1993 Jul; 18(1):61-5. PubMed ID: 8325622
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A, Borup T, Møller S, Bendtsen F.
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [Abstract] [Full Text] [Related]

  • 10. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y, Kanazawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Kidokoro H, Harimoto H, Fukuda T, Matsushita Y, Nakatsuka K, Sakamoto C.
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [Abstract] [Full Text] [Related]

  • 11. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G, Economou M, Paraskevi K, Konstantinos P, Pappas C, Katsaraki A, Tsianos EV.
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [Abstract] [Full Text] [Related]

  • 12. Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
    Romero G, Kravetz D, Argonz J, Bildozola M, Suarez A, Terg R.
    J Hepatol; 2000 Mar; 32(3):419-25. PubMed ID: 10735611
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison.
    Ding C, Wu X, Fan X, He C, Li J.
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1242-6. PubMed ID: 23489113
    [Abstract] [Full Text] [Related]

  • 14. Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
    Kalambokis G, Tsiouris S, Tsianos EV, Baltayiannis G, Pakou B, Fotopoulos A.
    Liver Int; 2010 Oct; 30(9):1371-8. PubMed ID: 20738780
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
    Badruddin AH, Rasool G, Chaudhry MA.
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):755-9. PubMed ID: 17125633
    [Abstract] [Full Text] [Related]

  • 16. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage.
    Tsai YT, Lee FY, Lin HC, Lee SD, Hsia HC, Lin WJ, Wang SS, Lay CS, Lai KH, Lo KJ.
    Hepatology; 1991 Mar; 13(3):407-12. PubMed ID: 1999311
    [Abstract] [Full Text] [Related]

  • 17. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
    García-Compeán D, Blanc P, Bories JM, Michel J, Desprez D, Pageaux GP, David XR, Larrey D, Michel H.
    Arch Med Res; 1997 Mar; 28(2):241-5. PubMed ID: 9204616
    [Abstract] [Full Text] [Related]

  • 18. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
    Pozzi M, Grassi G, Ratti L, Favini G, Dell'Oro R, Redaelli E, Calchera I, Boari G, Mancia G.
    Am J Gastroenterol; 2005 May; 100(5):1110-6. PubMed ID: 15842586
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats.
    Huang YT, Tsai JF, Lin HC, Chen CF, Hong CY.
    Can J Physiol Pharmacol; 1997 May; 75(10-11):1220-5. PubMed ID: 9431446
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
    McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, McIntyre N, Burroughs AK.
    Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.